Zolpidem (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zolpidem" in Italian language version.

refsWebsite

Global rank Italian rank

11nih.gov

4^th place

9^th place

3oadoi.org

799^th place

22^nd place

3doi.org

2^nd place

7^th place

doi.org

dx.doi.org

(EN) Björn Lemmer, The sleep-wake cycle and sleeping pills., in Physiology & Behavior, vol. 90, n. 2-3, Feb 2007, pp. 285-93, DOI:10.1016/j.physbeh.2006.09.006, PMID 17049955.
(EN) Russell P. Rosenberg, Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies., in Annals of Clinical Psychiatry, vol. 18, n. 1, 2006, pp. 49-56, DOI:10.1080/10401230500464711, PMID 16517453.
(EN) RE. Petroski, JE. Pomeroy; R. Das; H. Bowman; W. Yang; AP. Chen; AC. Foster, Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors., in J Pharmacol Exp Ther, vol. 317, n. 1, Apr 2006, pp. 369-77, DOI:10.1124/jpet.105.096701, PMID 16399882.

nih.gov

ncbi.nlm.nih.gov

(EN) Björn Lemmer, The sleep-wake cycle and sleeping pills., in Physiology & Behavior, vol. 90, n. 2-3, Feb 2007, pp. 285-93, DOI:10.1016/j.physbeh.2006.09.006, PMID 17049955.
(EN) Russell P. Rosenberg, Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies., in Annals of Clinical Psychiatry, vol. 18, n. 1, 2006, pp. 49-56, DOI:10.1080/10401230500464711, PMID 16517453.
(EN) H. Depoortere, B. Zivkovic; KG. Lloyd; DJ. Sanger; G. Perrault; SZ. Langer; G. Bartholini, Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects., in J Pharmacol Exp Ther, vol. 237, n. 2, maggio 1986, pp. 649-58, PMID 2871178.
(EN) A. Patat, MM. Naef; E. van Gessel; A. Forster; C. Dubruc; P. Rosenzweig, Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic., in Clin Pharmacol Ther, vol. 56, n. 4, Oct 1994, pp. 430-6, PMID 7955804.
(EN) NJ. Wesensten, TJ. Balkin; HQ. Davis; GL. Belenky, Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil., in Psychopharmacology (Berl), vol. 121, n. 2, Sep 1995, pp. 242-9, PMID 8545530.
(EN) ML. Perlis, WV. McCall; AD. Krystal; JK. Walsh, Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia., in J Clin Psychiatry, vol. 65, n. 8, Aug 2004, pp. 1128-37, PMID 15323600.
(EN) MB. Scharf, T. Roth; GW. Vogel; JK. Walsh, A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia., in J Clin Psychiatry, vol. 55, n. 5, maggio 1994, pp. 192-9, PMID 8071269.
(EN) RE. Petroski, JE. Pomeroy; R. Das; H. Bowman; W. Yang; AP. Chen; AC. Foster, Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors., in J Pharmacol Exp Ther, vol. 317, n. 1, Apr 2006, pp. 369-77, DOI:10.1124/jpet.105.096701, PMID 16399882.
(EN) C. Harter, E. Piffl-Boniolo; M. Rave-Schwank, [Development of drug withdrawal delirium after dependence on zolpidem and zoplicone]., in Psychiatr Prax, vol. 26, n. 6, Nov 1999, p. 309, PMID 10627964.
(EN) Hypnotic dependence: zolpidem and zopiclone too., in Prescrire Int, vol. 10, n. 51, Feb 2001, p. 15, PMID 11503851.
(EN) PK. Sethi, DC. Khandelwal, Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure., in J Assoc Physicians India, vol. 53, Feb 2005, pp. 139-40, PMID 15847035.

oadoi.org

(EN) Björn Lemmer, The sleep-wake cycle and sleeping pills., in Physiology & Behavior, vol. 90, n. 2-3, Feb 2007, pp. 285-93, DOI:10.1016/j.physbeh.2006.09.006, PMID 17049955.
(EN) Russell P. Rosenberg, Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies., in Annals of Clinical Psychiatry, vol. 18, n. 1, 2006, pp. 49-56, DOI:10.1080/10401230500464711, PMID 16517453.
(EN) RE. Petroski, JE. Pomeroy; R. Das; H. Bowman; W. Yang; AP. Chen; AC. Foster, Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors., in J Pharmacol Exp Ther, vol. 317, n. 1, Apr 2006, pp. 369-77, DOI:10.1124/jpet.105.096701, PMID 16399882.